Bristol-Myers Squibb: Why Is US Pharma Giant Bristol Myers Squibb Stock Trading Lower On Tuesday?
Bristol Myers' Camzyos missed goals in a Phase 3 nHCM trial, showing no significant benefits over placebo but raised no new safety concerns. read more
Read full article »
Bristol Myers Squibb is a New Jersey-based biopharmaceutical company that discovers, develops and commercializes medicines for patients with serious diseases.
Read more